Mesenteric Panniculitis: Overview
Yes, mesenteric panniculitis (MP) is a well-recognized benign inflammatory disorder affecting the adipose tissue of the mesentery, most commonly involving the small bowel mesentery. This condition is characterized by chronic inflammation and fibrosis of mesenteric fat and is frequently discovered incidentally on cross-sectional imaging 1.
Clinical Presentation
MP presents with a wide spectrum of manifestations:
- Asymptomatic in up to 50% of cases - often discovered incidentally on CT imaging performed for other indications 1
- Symptomatic presentations include:
The condition predominantly affects older adults (mean age ~72 years) with equal sex distribution 3.
Diagnostic Approach
CT with IV contrast is the imaging modality of choice and demonstrates characteristic findings 1:
- "Misty mesentery" appearance - mass-like area of increased fat attenuation within the small bowel mesentery, typically in the left upper quadrant 4, 2
- "Fat-ring sign" - preservation of fat around mesenteric vessels
- The mass envelops mesenteric vessels and displaces adjacent bowel segments
- Small mesenteric lymph nodes are frequently present within the abnormal area 4
Important Diagnostic Pitfall
The primary differential diagnosis is lymphoma, and PET/CT may be necessary if there is suspicion of concurrent malignancy 1. This is critical because MP can be associated with underlying malignancy in secondary forms 3.
Classification and Associated Conditions
MP is classified as:
- Primary (61.3% of cases) - idiopathic, no associated condition 3
- Secondary (38.7% of cases) - associated with:
In the context of neuroendocrine tumors (NENs), mesenteric fibrosis (desmoplasia) represents a related but distinct entity that can cause significant complications including bowel obstruction and mesenteric vessel compromise 5.
Management Strategy
For Asymptomatic Cases
- Observation with surveillance imaging is appropriate 3
- 85.6% of patients remain clinically stable during follow-up 3
For Symptomatic Cases
First-line medical therapy consists of:
- Prednisone (glucocorticoids) - shows good clinical and radiological response 2, 6
- Tamoxifen - alternative or adjunctive therapy 1
- Other options include azathioprine or colchicine for steroid-sparing effect 6
Glucocorticoids typically provide substantial symptom relief within 72 hours in responsive cases 2.
Surgical Intervention
Surgery is reserved for specific complications:
- Recurrent bowel obstruction 1
- Abscess formation (rare complication) 7
- Cases refractory to medical therapy 6
When surgery is performed, resection of affected bowel segments with primary anastomosis is the typical approach 7.
Special Consideration in NEN-Related Mesenteric Fibrosis
For patients with NENs and mesenteric fibrosis 5:
- Surgical management should be considered even in metastatic settings if quality of life is significantly impaired and prognosis from the NEN is reasonable
- Early dietetic input is essential to prevent malnutrition
- Long-term home parenteral nutrition may be necessary if surgical risks are prohibitive
- Corticosteroids may have a role, though evidence is limited
Prognosis
The overall prognosis is generally favorable:
- Most cases follow an indolent course, particularly primary forms 3
- Overall mortality is 8.1%, slightly higher in secondary forms associated with malignancy 3
- Patients on prednisone demonstrate good clinical and radiological responses during follow-up 6
Key Clinical Pearls
- Always exclude underlying malignancy, particularly in elderly patients with weight loss and suspicious imaging findings 4, 2
- CT is diagnostic in most cases; biopsy is rarely necessary unless malignancy cannot be excluded 2
- Treatment should be guided by symptom severity - asymptomatic cases do not require intervention 1
- Annual surveillance is appropriate for diagnosed cases to monitor stability 2
- Be aware that this condition can occasionally progress to complications like abscess formation, though this is rare 7